Helping You Build Wealth With Honest Research
Since 1996. Read On...

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

HIKAL CHEMIC Gains 6%; BSE HEALTHCARE Index Down 0.2%
Mon, 9 Sep 9:59

HIKAL CHEMIC Gains 6%; BSE HEALTHCARE Index Down 0.2%Image source: hudiemm/www.istockphoto.com

HIKAL CHEMIC share price has zoomed 6% and is presently trading at Rs 363.2.

Meanwhile, the BSE HEALTHCARE index is at 43,395.6 (down 0.2%).

Among the top gainers in the BSE HEALTHCARE index today are ALEMBIC PHARMA (up 4.0%) and NARAYANA HRUDAYALAYA (up 2.8%).

Lupin (down 2.5%) and GRANULES INDIA (down 2.4%) are among the top losers today.

Over the last one year, HIKAL CHEMIC has moved up from Rs 308.3 to Rs 363.2, registering a gain of Rs 54.9 (up 17.8%).

On the other hand, the BSE HEALTHCARE index has moved up from 28,163.1 to 43,395.6, registering a gain of 54.1% during the last 12 months.

The top gainers among the BSE HEALTHCARE index stocks during this same period were SUVEN PHARMACEUTICALS (up 136.1%), GRANULES INDIA (up 115.6%) and Glenmark Pharma (up 115.1%).

Must See: These Segments are Witnessing Incredible Growth with Modi's Push

What About the Benchmark Indices?

The BSE Sensex is at 81,180.3 .

The top losers among the BSE Sensex today are NTPC (down 1.4%) and MUNDRA PORT & SEZ (down 1.4%). The most traded stocks in the BSE Sensex are Tata Steel and SBI.

In the meantime, NSE Nifty is at 24,838.4 (down 0.1%). ONGC and Hindalco are among the top losers in NSE NIFTY.

Over the last 12 months, the BSE Sensex has moved up from 65,780.3 to 81,180.3, registering a gain of 15,400.1 points (up 23.4%).

HIKAL CHEMIC Financial Update...

HIKAL CHEMIC net profit fell 26.1% YoY to Rs 51 million for the quarter ended June 2024, compared to a profit of Rs 69 million a year ago. Net sales rose 4.8% to Rs 4,068 million during the period as against Rs 3,880 million in April-June 2023.

For the year ended March 2024, HIKAL CHEMIC reported 11.2% decrease in net profit to Rs 696 million compared to net profit of Rs 784 million during FY23. Revenue of the company fell 11.8% to Rs 17,846 million during FY24.

The current Price to earnings ratio of HIKAL CHEMIC, based on rolling 12 month earnings, stands at 66.1.


Equitymaster requests your view! Post a comment on "HIKAL CHEMIC Gains 6%; BSE HEALTHCARE Index Down 0.2%". Click here!